Application of a new immunohistology scoring system (IH score): Analysis of TNF-α in synovium related to disease activity score in infliximab-treated patients with rheumatoid arthritis

Modern Rheumatology

Volumn 24, Issue 6, 2014, Pages 910-914

  Kanbe, Katsuaki ^a   Hara, Ryota ^b   Chiba, Junji ^a   Inoue, Yasuo ^a   Taguchi, Masashi ^a   Tanaka, Yasuhito ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Histology; Infliximab; Rheumatoid arthritis; Synovium; TNF

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE; INFLIXIMAB; INTERLEUKIN 6; PEPTIDES AND PROTEINS; PREDNISOLONE; RHEUMATOID FACTOR; STROMELYSIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY SCORE; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY SCORING SYSTEM; MALE; MIDDLE AGED; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ROONEY SCORE; SYNOVECTOMY; TREATMENT DURATION; VISUAL ANALOG SCALE; AGED; ARTHRITIS, RHEUMATOID; IMMUNOHISTOCHEMISTRY; METABOLISM; OBSERVER VARIATION; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SYNOVIUM; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MIDDLE AGED; OBSERVER VARIATION; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84932142778     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2014.887047     Document Type: Article

References (16)

1. Sweeney SE, Firestein GS. Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol. 2004;36(3):372-8.
2. Kanbe K, Takagishi K, Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell- derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum. 2002;46(1): 130-7.
3. Klarenbeek NB, Güler-Yüksel M, van der Kooij SM, Han KH, Ronday HK, Kerstens PJ, et al. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study. Ann Rheum Dis. 2011;70(6): 1039-46.
4. Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 1997;40(2):217-25.
5. Youssef PP, Smeets TJ, Bresnihan B, Cunnane G, Fitzgerald O, Breedveld F, Tak PP. Microscopic measurement of cellular infiltration in the rheumatoid arthritis synovial membrane: a comparison of semiquantitative and quantitative analysis. Br J Rheumatol. 1998; 37(9): 1003-7.
6. Kraan MC, Smith MD, Weedon H, Ahern MJ, Breedveld FC, Tak PP. Measurement of cytokine and adhesion molecule expression in synovial tissue by digital image analysis. Ann Rheum Dis. 2001:60(3):296-8.
7. Rooney T, Bresnihan B, Andersson ULF, Gogarty M, Kraan M, Ralph H, et al. Microscopic measurement of inflammation in synovial tissue: inter-observer agreement for manual quantitative, semiquantitative and computerized digital image analysis. Ann Rheu Dis. 2007;66(12): 1656-60.
8. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn. 1977; 18(4):481-91.
9. Rooney M, Condell D, Quinlan W, Daly L, Whelan A, Feighery C, Bresnihan B. Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum. 1988;31(8):956-63.
10. Kanbe K, Inoue K, Inoue Y, Suzuki Y. Histological analysis of synovium in cases of effect attenuation associated with infliximab therapy in rheumatoid arthritis. Clin Rheum. 2008:27(6):777-81.
11. Knudsen LS, Ostergaard M, Baslund B, Narvestad E, Petersen J, Nielsen HJ, et al. Plasma IL-6, plasma VEF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate. Scand J Rheumatol. 2006;35(6):489-91.
12. Takeuchi T, Miyasaka N, Tatsuki Y, Yano T, Yoshinari T, Abe T, Koike T. Inhibition of plasma IL-6 in addition to maintenance of an efficacious trough level of infliximab associated clinical remission in patients with rheumatoid arthritis: analysis of the RISING Study. Ann Rheum Dis. 2012;71(9): 1583-5.
13. Bresnihan B, Tak PP, Emery P, Klareskog L, Breedveld F. Synovial biopsy in arthritis research: five years of concerted European collaboration. Ann Rheum Dis. 2000;59(7):506-11.
14. Youssef PP, Kraan M, Breedveld F, Bresnihan B, Cassidy N, Cunnane G, et al. Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy. Arthritis Rheum. 1998;41(4):663-9.
15. Parker RH, Pearson CM. A simplified synovial biopsy needle. Arthritis Rheum. 1963;6:172-6.
16. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol. 2000;27(l):261-3.